Week in Review: Hansoh Plans Hong Kong IPO To Raise up to $1 Billion

Hansoh Pharma, an established drug company, has filed for a Hong Kong IPO, and is rumored to seek between $500 million and $1 billion in new capital. It's a profitable drug company with $1.1 billion in revenue and more than $280 million in profits.